HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianjun Deng Selected Research

ginsenoside Rk3

2/2024Ginsenoside Rk3 modulates gut microbiota and regulates immune response of group 3 innate lymphoid cells to against colorectal tumorigenesis.
2/2024Ginsenoside Rk3 Ameliorates Obesity-Induced Colitis by Modulating Lipid Metabolism in C57BL/6 Mice.
5/2023Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma.
3/2021Ginsenoside Rk3 Ameliorates Obesity-Induced Colitis by Regulating of Intestinal Flora and the TLR4/NF-κB Signaling Pathway in C57BL/6 Mice.
5/2019Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
4/2019Protective effects of ginsenoside Rk3 against chronic alcohol-induced liver injury in mice through inhibition of inflammation, oxidative stress, and apoptosis.
4/2018Anti-anemia effects of ginsenoside Rk3 and ginsenoside Rh4 on mice with ribavirin-induced anemia.
10/2017Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianjun Deng Research Topics

Disease

15Neoplasms (Cancer)
03/2024 - 01/2017
14Inflammation (Inflammations)
02/2024 - 10/2018
6Insulin Resistance
10/2023 - 01/2017
5Type 2 Diabetes Mellitus (MODY)
02/2021 - 06/2015
5Lung Neoplasms (Lung Cancer)
10/2020 - 08/2018
3Obesity
02/2024 - 03/2021
3Dyslipidemias (Dyslipidemia)
10/2023 - 05/2016
3Hepatocellular Carcinoma (Hepatoma)
05/2023 - 01/2015
3Mesothelioma
10/2020 - 08/2018
2Dysbiosis
03/2024 - 05/2020
2Colitis
02/2024 - 03/2021
2Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
02/2024 - 05/2016
2Surgical Wound Infection
10/2023 - 05/2022
2Diabetes Mellitus
10/2023 - 05/2022
2Pneumonia (Pneumonitis)
10/2022 - 10/2020
2Cytokine Release Syndrome
10/2021 - 01/2020
2Pulmonary Fibrosis (Fibrosing Alveolitis)
09/2021 - 08/2018
2Hyperglycemia
02/2021 - 05/2019
2Anemia
07/2019 - 04/2018
2Lung Injury
06/2019 - 08/2018
2Asbestosis
06/2019 - 08/2018
2Osteoporosis
12/2018 - 02/2018
1Mucositis
03/2024
1Carcinogenesis
02/2024
1Chronic Disease (Chronic Diseases)
11/2023
1Cross Infection (Nosocomial Infection)
10/2023
1Metabolic Diseases (Metabolic Disease)
10/2023
1Neuroinflammatory Diseases
09/2023
1COVID-19
01/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2022
1Hypertension (High Blood Pressure)
10/2022
1Phobic Disorders (Phobia)
06/2022
1Wounds and Injuries (Trauma)
05/2022
1Hypoproteinemia
05/2022
1Surgical Wound
05/2022
1Neoplasm Metastasis (Metastasis)
10/2021
1Lung Diseases (Lung Disease)
09/2021

Drug/Important Bio-Agent (IBA)

8ginsenoside Rk3IBA
02/2024 - 10/2017
7Glucose (Dextrose)FDA LinkGeneric
10/2023 - 01/2017
5ginsenoside Rh4IBA
03/2024 - 01/2018
5Serpentine Asbestos (Chrysotile)IBA
10/2020 - 08/2018
4LipidsIBA
02/2024 - 05/2016
4AlkaloidsIBA
11/2023 - 11/2018
4AsbestosIBA
10/2020 - 08/2018
3Insulin (Novolin)FDA Link
10/2023 - 05/2019
3EicosanoidsIBA
01/2023 - 01/2020
3CytokinesIBA
01/2023 - 01/2020
3nuciferineIBA
01/2023 - 10/2018
3Streptozocin (Streptozotocin)FDA Link
02/2021 - 01/2017
3SaponinsIBA
07/2019 - 01/2017
3GinsenosidesIBA
05/2019 - 01/2017
2PhytochemicalsIBA
11/2023 - 03/2021
2aporphineIBA
11/2023 - 01/2023
2Anti-Bacterial Agents (Antibiotics)IBA
10/2023 - 07/2019
2InterferonsIBA
10/2022 - 04/2018
2Epoxide HydrolasesIBA
10/2021 - 01/2020
2Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2021
2ginsenoside Rg5IBA
08/2021 - 05/2020
2GlycogenIBA
08/2021 - 11/2020
2Hypoglycemic Agents (Hypoglycemics)IBA
05/2020 - 06/2015
2protopanaxatriolIBA
07/2019 - 01/2017
2CollagenIBA
12/2018 - 03/2016
1hyodeoxycholic acidIBA
03/2024
1Irinotecan (Camptosar)FDA LinkGeneric
03/2024
1Bile Acids and Salts (Bile Acids)IBA
03/2024
1Benzo(a)pyreneIBA
02/2024
1Calcium Sulfate (Alabaster)IBA
02/2024
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
02/2024
1Linoleic Acid (Linoleate)IBA
02/2024
1Arachidonic Acid (Vitamin F)IBA
02/2024
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2024
1isoquinolineIBA
11/2023
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
10/2023
1Insulin ReceptorIBA
10/2023
1Tyrosine (L-Tyrosine)FDA Link
10/2023
1ginsenoside F4IBA
10/2023
1Insulin Receptor Substrate ProteinsIBA
10/2023
1Amyloid (Amyloid Fibrils)IBA
09/2023
1Glycogen Synthase KinasesIBA
09/2023
1PolyphenolsIBA
01/2023
1C-Reactive ProteinIBA
01/2023
1Lactic Acid (Lactate)FDA LinkGeneric
01/2023
1CholesterolIBA
01/2023
1palmitoyl glycerolIBA
01/2023
1Antihypertensive Agents (Antihypertensives)IBA
10/2022
1Proanthocyanidins (Procyanidins)IBA
10/2022
1Interleukin-13IBA
10/2022
1Interleukin-5 (Interleukin 5)IBA
10/2022
1Interleukin-4 (Interleukin 4)IBA
10/2022
1Particulate MatterIBA
10/2022
1Dinoprostone (PGE2)FDA Link
10/2021
1Circular RNAIBA
09/2021

Therapy/Procedure

7Therapeutics
03/2024 - 02/2013
4Drug Therapy (Chemotherapy)
03/2024 - 10/2021
1Fecal Microbiota Transplantation
02/2024
1Blood Transfusion (Blood Transfusions)
10/2023
1Gynecologic Surgical Procedures (Gynecologic Surgery)
10/2023
1Length of Stay
10/2023
1Hysterectomy
05/2022